Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

COPENHAGEN (Reuters) -Drugmaker Novo Nordisk said on Monday it would halt its Wegovy weight-loss drug agreement with U.S.

Prescriptions for Mounjaro jabs, to help people lose weight, will be available at GP surgeries in England from today - but ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Omnicom's $13.5 billion acquisition of rival Interpublic can move forward on the condition the new company does not enter ...

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...

Doctors say there have been a number of developments with new weight loss drugs, which could make them easier for patients to ...